Delivery Order SPE2DB20D3111-SPE2DB25FA9BN
- Not listed
- The Defense Logistics Agency awarded a $3,029.76 delivery order to AmerisourceBergen Drug Corp for Telmisartan 80 mg tablets (30-count) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 13, 2025, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract carries a ceiling value of $1,924.44 with a firm fixed price structure and an ultimate completion date of August 14, 2025. AmerisourceBergen, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving federal medical procurement needs,...
- The Defense Logistics Agency awarded a delivery order valued at $3,006.30 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) under a firm fixed price contract. The award, issued on August 13, 2025, with an ultimate completion date of August 14, 2025, represents a non-set-aside competitive award. Performance of this delivery order will be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract is a child order...
- The Defense Logistics Agency awarded a delivery order valued at $4,832.84 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count units) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed-price delivery order with no set-aside designation, awarded competitively through an open procurement process. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, for the supply of Telmisartan 80 mg tablets in quantities of 30 units. This competitively awarded, non-set-aside contract was executed on August 4, 2025, with a ceiling value of $3,660.86 and an ultimate completion date of August 5, 2025. The contract utilizes firm fixed pricing and represents a delivery order under...
- The Defense Logistics Agency awarded a delivery order valued at $2,849.20 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Telmisartan 80 mg tablets in quantities of 30. The contract employs firm fixed-price pricing with no set-aside designation, indicating competitive award procedures. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count packages) under a firm fixed-price contract valued at $3,808.62. This competitive award, issued on July 30, 2025, with an ultimate completion date of July 31, 2025, represents a child delivery order executed against AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The place of performance is located at the contractor's...
- The Defense Logistics Agency awarded a delivery order valued at $1,093.50 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count packaging) on August 14, 2025, with completion scheduled for August 15, 2025. This firm fixed-price delivery order represents a competitive award with no set-aside designation and is performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The contract falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order valued at $1,029.32 to AmerisourceBergen Drug Corp for the supply of Telmisartan 40 mg tablets (30-count) on August 21, 2025, with a completion date of August 22, 2025. This non-set-aside, competitively awarded contract employs firm fixed price terms and designates AmerisourceBergen's Conshohocken, Pennsylvania location as the place of performance. The award represents a child contract under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 20, 2025, for the supply of Telmisartan 20 mg tablets in quantities of 30 units. This contract, valued at $6,670.08, represents a firm fixed price delivery order with an ultimate completion date of August 21, 2025. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's demonstrated capability to meet federal pharmaceutical procurement requirements. The...
- SPE2DB20D3111Indefinite Delivery Contract
- SPE2DB20D3111-SPE2DB25FA9BNDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,773.00 to AmerisourceBergen Drug Corp for the supply of Telmisartan 80 mg tablets (30-count) on August 25, 2025, with completion scheduled for August 26, 2025. The contract is structured as a firm fixed price delivery order with no set-aside designation, indicating competitive award. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location in Conshohocken, PA 19428. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026. This prime contract vehicle serves as a comprehensive global pharmaceutical support mechanism enabling the contractor to supply a wide range of pharmaceutical products and medical supplies to support military healthcare programs worldwide. The Telmisartan delivery represents a routine pharmaceutical procurement supporting the Defense Health Agency and other federal healthcare systems through DLA's Medical Supply Chain.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 8/25/25 |